King Wealth Management Group’s Halozyme HALO Stock Holding History

King Wealth Management Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,000	Closed	-$201K	–	177
2021 Q4	$201K	Hold	5,000	–	–	0.04%	168
2021 Q3	$203K	Hold	5,000	–	–	0.04%	166
2021 Q2	$227K	Sell	5,000 -5,000	-50%	-$221K	0.05%	158
2021 Q1	$417K	Sell	10,000 -5,000	-33%	-$228K	0.09%	106
2020 Q4	$641K	Sell	15,000 -2,000	-12%	-$71.9K	0.15%	78
2020 Q3	$447K	Hold	17,000	–	–	0.12%	93
2020 Q2	$456K	Sell	17,000 -5,000	-23%	-$113K	0.13%	88
2020 Q1	$396K	Buy	+22,000	New	+$418K	0.17%	71

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

King Wealth Management Group's HALO Position: Q1 2022 in Review

King Wealth Management Group sold out of Halozyme (HALO) in Q1 2022, closing a stake of 5,000 shares — an estimated $201K sold.

King Wealth Management Group first reported a position in HALO in Q1 2020 and held it in 8 quarters. The position peaked at $641K in Q4 2020. 316 funds tracked by Wall St. Rank hold HALO as of Q1 2022.

King Wealth Management Group reported no remaining Halozyme position as of Q1 2022 after selling out during the quarter.
King Wealth Management Group sold 5,000 Halozyme shares in Q1 2022, an estimated $201K.
King Wealth Management Group first reported a position in Halozyme in Q1 2020 and held it in 8 quarters.
King Wealth Management Group's Halozyme position peaked at $641K in Q4 2020.
316 funds tracked by Wall St. Rank held Halozyme as of Q1 2022.

Based on King Wealth Management Group's 13F filing for Q1 2022, filed 12 May 2022.